BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38878177)

  • 1. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
    Nofal A; Alakad R; Wahid R; Hoseiny HAM
    Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
    Aubut N; Alain J; Claveau J
    J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
    Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
    Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
    Moss M; Weber E; Hoverson K; Montemarano AD
    Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
    Doerfler L; Hanke CW
    J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional therapy for the treatment of keratoacanthoma.
    Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
    Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.
    Rossi AM; Park B; Qi B; Lee EH; Busam KJ; Nehal KS
    Dermatol Surg; 2017 Jun; 43(6):810-816. PubMed ID: 28296794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eruptive Keratoacanthomas in a Red Tattoo.
    Linares-Gonzalez L; Ródenas-Herranz T; Galvez-Moreno M; Ruiz-Villaverde R
    Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e372-e373. PubMed ID: 33110656
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report.
    de Visscher JG; van der Wal KG; Blanken R; Willemse F
    J Oral Maxillofac Surg; 2002 Jan; 60(1):93-5. PubMed ID: 11757016
    [No Abstract]   [Full Text] [Related]  

  • 11. Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
    Que SKT; Compton LA; Schmults CD
    J Am Acad Dermatol; 2019 Jul; 81(1):111-122. PubMed ID: 31103317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of keratoacanthoma with intralesional fluorouracil.
    Goette DK; Odom RB
    J Am Acad Dermatol; 1980 Mar; 2(3):212-6. PubMed ID: 7364978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
    Maghfour J; Kuraitis D; Murina A
    J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of keratoacanthoma: Is intralesional methotrexate an option?
    Patel NP; Cervino AL
    Can J Plast Surg; 2011; 19(2):e15-8. PubMed ID: 22654538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip.
    Spieth K; Gille J; Kaufmann R
    Dermatology; 2000; 200(4):317-9. PubMed ID: 10894963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional methotrexate for the treatment of keratoacanthoma: retrospective study and review of the korean literature.
    Yoo MG; Kim IH
    Ann Dermatol; 2014 Apr; 26(2):172-6. PubMed ID: 24882970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional methotrexate for keratoacanthoma of the nose.
    Cohen PR; Schulze KE; Teller CF; Nelson BR
    Skinmed; 2005; 4(6):393-5. PubMed ID: 16276163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional methotrexate in keratoacanthoma of the nose.
    Hurst LN; Gan BS
    Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
    Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
    Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.